| Financial Year |
March 31 2023 |
| Monetary Funds |
234,526,577.26 |
| Held-for-trading Financial Assets |
230,000,000.00 |
| Notes Receivable |
5,000,000.00 |
| Accounts Receivable |
238,687,823.33 |
| Advances to Suppliers |
7,601,615.28 |
| Other Receivables |
42,912,529.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,307,488.45 |
| Inventories |
40,211,831.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,315,738.44 |
| Total Current Assets |
810,256,115.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
90,406,548.95 |
| Investment Properties |
-- |
| Fixed Assetes |
592,257,232.68 |
| Under-construction Projects |
101,978,196.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
144,947,694.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,900,556.41 |
| Deferred Income Tax Assets |
54,200,737.77 |
| Other Non-Current Assets |
7,104,748.05 |
| Sub-Total of Non-Current Assets |
1,601,511,011.23 |
| Total Assets |
2,411,767,126.34 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
55,431,985.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,732,351.89 |
| Taxes Payable |
9,387,513.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,461,954.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
103,435,478.44 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
251,593,543.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
49,953,175.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
278,040,120.69 |
| Total Liabilities |
529,633,664.37 |
| Paid-In Capital(Or Share Stock) |
362,412,800.00 |
| Capital Surplus |
857,088,243.33 |
| Surplus Reserve |
121,811,307.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
523,434,174.24 |
| Minority Stockholder's Interest |
17,024,757.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,865,108,704.36 |
| Owner's Equity（Stockholder's Equity） |
1,882,133,461.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,411,767,126.34 |
